Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202604807781933Phase 4Not yet recruiting
Phase 4, randomised, open-label trial comparing Misoprostol group with Oxytocin group (2 arms). Primary endpoints: Induction to delivery interval and Caesarean section rate. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202604807781933.